Riskpilot← Back to searchSign inGet full accessFamedic AB
ABDissolvedOrg 5564274982Economic activity was not specified by tax authority · NACE 0000Est. 19910 employees
Revenue 2023
SEK 51,4M
+66% vs 2022
EBITDA margin
27.8%
+22% vs 2022
Equity ratio
98.1%
Financial strength
Net profit 2023
SEK 11,3M
+23% vs 2022
| Revenue | SEK 51,4M | +66% |
| EBITDA | SEK 14,3M | +22% |
| Net profit | SEK 11,3M | +23% |
| Total assets | SEK 153,8M | +1% |
| Equity | SEK 150,8M | +1% |
| Employees | 0 | — |
Legal name
Famedic AB
Org number
5564274982
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
3 juni 1991
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva handel med värdepapper.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 29 351 | 14 866 | 39 215 | 30 920 | 51 370 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 9 428 | 766 | 9 504 | 11 669 | 14 292 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 9 428 | 766 | 9 504 | 11 669 | 14 292 |
| Net financials | −2 | — | — | — | 70 |
| Profit before tax | 9 426 | 766 | 9 504 | 11 669 | 14 362 |
| Tax | −2 176 | −220 | −2 116 | −2 500 | −3 077 |
| Net profit | 7 250 | 546 | 7 388 | 9 169 | 11 285 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 149 473 | 145 255 | 150 657 | 151 703 | 153 808 |
| Equity | 147 227 | 145 073 | 150 461 | 149 630 | 150 815 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 246 | 182 | 196 | 2 074 | 2 993 |
| Total debt | 2 246 | 182 | 196 | 2 074 | 2 993 |
EBITDA margin
27.8%
This company
15.8%
Market median
+76% vs market
20192023
Equity ratio
98.1%
This company
38.2%
Market median
+157% vs market
20192023
Return on equity
7.5%
This company
18.4%
Market median
-59% vs market
20192023
Net profit margin
22.0%
This company
8.1%
Market median
+172% vs market
20192023
Asset turnover
0.33×
This company
1.12×
Market median
-71% vs market
20192023
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-05-01 – 2019-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SK | Audit | 2022 |
| Former (1) | ||
LM Audit | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
| Deputy Board Member | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Famedic Holding AB
Famedic AB Board members of Famedic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stig Krister Holmgren | Audit | 0 companies |
| Liz Maria Borg | Audit | 0 companies |
| Madeleine Christina du Rées | Board of Directors | 0 companies |
| Stephan David Louis du Rées | Deputy Board Member | 0 companies |
| Helena Christina du Rées | Deputy Board Member | 0 companies |